Cargando…
Repetitive milrinone therapy in ambulatory advanced heart failure patients
BACKGROUND: Advanced heart failure (HF) patients usually poorly tolerate guideline‐directed HF medical therapy (GDMT) and suffer high rates of morbidity and mortality. The use of continuous inotropes in the outpatient settings is hampered by previous data showing excess morbidity. We aimed to assess...
Autores principales: | Laufer‐Perl, Michal, Sadon, Sapir, Zahler, David, Milwidsky, Assi, Sadeh, Ben, Sapir, Orly, Granot, Yoav, Korotetski, Liuba, Ketchker, Liora, Rosh, Maayan, Banai, Shmuel, Havakuk, Ofer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045071/ https://www.ncbi.nlm.nih.gov/pubmed/35243658 http://dx.doi.org/10.1002/clc.23802 |
Ejemplares similares
-
Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients
por: Milwidsky, Assi, et al.
Publicado: (2022) -
Successful conservative management of left ventricular assist device candidates
por: Havakuk, Ofer, et al.
Publicado: (2022) -
Cardiorespiratory Abnormalities in Patients Recovering from Coronavirus Disease 2019
por: Szekely, Yishay, et al.
Publicado: (2021) -
Risk stratification according to diastolic function indices in heart failure patients with mildly reduced or reduced ejection fraction
por: Granot, Yoav, et al.
Publicado: (2023) -
The added predictive role of echocardiography in patients with mild or moderate Coronavirus Disease 2019
por: Lupu, Lior, et al.
Publicado: (2023)